Xilio Therapeutics XLO
NASDAQ XLO
$8.31 -0.09 (-1.06%)
As of: Oct 22, 2026 · 11:51 AM EDT

Xilio Therapeutics (XLO) Cash from Financing Activities (2020 - 2026)

Updated

Xilio Therapeutics' Cash from Financing Activities came in at $4.49 million for Q2 2026, down 90.5% from $47.36 million a year earlier and down 87.4% from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Xilio Therapeutics reported Cash from Financing Activities of $75.78 million, up 25.5% year-over-year; for FY2025, it was $87.78 million, up 200.6% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of 54.3% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $29.2 million in FY2024, -$6.55 million in FY2023, -$69,000 in FY2022 and $260.67 million in FY2021.
  • The five-year range for quarterly Cash from Financing Activities is -$2.24 million (Q3 2023) to $115.83 million (Q4 2021).
  • Year-over-year, Cash from Financing Activities increased in four of the last five quarters, with growth averaging 285.7%.
  • Business Quant data shows XLO's Cash from Financing Activities at $35.71 million (Q1 2026), $35.87 million (Q4 2025) and -$285,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,170.57 Bn 1,139.16 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 641.68 Bn 560.21 Bn 17.26 Bn -8.78 Bn
3 AbbVie 502.16 Bn 475.27 Bn 12.70 Bn -5.05 Bn
4 Merck 375.54 Bn 329.92 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 302.70 Bn 266.69 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 268.54 Bn 242.22 Bn 12.86 Bn -3.89 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn 2.34 Bn
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn -3.66 Bn
10 Xilio Therapeutics 161.25 Mn -366.42 Mn - 4.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.49 Mn
Mar 31, 2026 35.71 Mn
Dec 31, 2025 35.87 Mn
Sep 30, 2025 -285,000.00
Jun 30, 2025 47.36 Mn
Mar 31, 2025 4.83 Mn
Dec 31, 2024 8.20 Mn
Sep 30, 2024 -3,000.00
Jun 30, 2024 20.04 Mn
Mar 31, 2024 954,000.00
Dec 31, 2023 -1.63 Mn
Sep 30, 2023 -2.24 Mn
Jun 30, 2023 -992,000.00
Mar 31, 2023 -1.69 Mn
Dec 31, 2022 -21,000.00
Sep 30, 2022 -22,000.00
Jun 30, 2022 -21,000.00
Mar 31, 2022 -5,000.00
Dec 31, 2021 115.83 Mn
Sep 30, 2021 301,000.00
API Access

Xilio Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=XLO&period=max&api_key=YOUR_API_KEY